Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Soleno Therapeutics Inc. buy Laidlaw

Start price
€61.65
27.03.25 / 50%
Target price
€97.53
27.03.26
Performance (%)
-28.14%
Price
?
07:36
Summary
This prediction is currently active. The price of Soleno Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -28.14%. This prediction currently runs until 27.03.26. The prediction end date can be changed by Laidlaw at any time. Laidlaw has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Soleno Therapeutics Inc. -4.663% -4.663%
iShares Core DAX® 0.734% 1.458%
iShares Nasdaq 100 -2.686% -0.146%
iShares Nikkei 225® -2.261% -2.729%
iShares S&P 500 -1.346% 0.467%

Comments by Laidlaw for this prediction

In the thread Soleno Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -28.14%
Target price 97.535
Change
Ends at 27.03.26

Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Laidlaw from $75.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat